Clinical Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, D. L.
Right arrow Articles by De Luca, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, D. L.
Right arrow Articles by De Luca, L. M.
Clinical Cancer Research Vol. 6, 3636-3645, September 2000
© 2000 American Association for Cancer Research


Experimental Therapeutics, Preclinical Pharmacology

Topical Delivery of 13-cis-Retinoic Acid by Inhalation Up-Regulates Expression of Rodent Lung but not Liver Retinoic Acid Receptors

Da Li Wang, Melissa Marko, Alan R. Dahl, Kory S. Engelke1, Michael E. Placke, Anthony R. Imondi, James L. Mulshine and Luigi M. De Luca2

Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, Bethesda, Maryland 20892 [D. L. W., M. M., L. M. D.]; Battelle Memorial Institute, Columbus, Ohio 43201-2693 [A. R. D., K. S. E., M. E. P., A. R. I.]; and Medicine Branch, National Cancer Institute, Bethesda, Maryland 20892 [J. L. M.]

Chemopreventive retinoids may be more effective if delivered to the lung epithelium by inhalation. 13-cis-Retinoic acid (13-cis-RA) was comparable to all-trans-retinoic acid (RA) in inducing transglutaminase II (TGase II) in cultured human cells. Inhaled 13-cis-RA had a significant stimulatory activity on TGase II in rat lung (P < 0.001) but not in liver tissue (P < 0.544). Furthermore, inhaled 13-cis-RA at daily deposited doses of 1.9 mg/kg/day up-regulated the expression of lung retinoic acid receptors (RARs) {alpha}, ß, and {gamma} at day 1 (RAR{alpha} by 3.4-fold, RARß by 7.2-fold, and RAR{gamma} by 9.7-fold) and at day 17 (RAR{alpha} by 4.2-fold, RARß by 10.0-fold, and RAR{gamma} by 12.9-fold). At a lower aerosol concentration, daily deposited doses of 0.6 mg/kg/day were also effective at 28 days. Lung RAR{alpha} was induced by 4.7-fold, RARß by 8.0-fold, and RAR{gamma} by 8.1-fold. Adjustment of dose by exposure duration was also effective; thus, inhalation of an aerosol concentration of 62.2 µg/liter, for durations from 5 to 240 min daily for 14 days, induced all RARs from 30.6- to 74-fold at the shortest exposure time. None of the animals exposed to 13-cis-RA aerosols showed RAR induction in livers. By contrast, a diet containing pharmacological RA (30 µg/g of diet) failed to induce RARs in SENCAR mouse lung, although it induced liver RARs (RAR{alpha}, 21.8-fold; RARß, 13.5-fold; RAR{gamma}, 12.5-fold); it also failed to induce lung TGase II. A striking increase of RAR{alpha} expression was evident in the nuclei of hepatocytes. Pharmacological dietary RA stimulated RAR{alpha}, RARß, and RAR{gamma} as early as day 1 by 2-, 4-, and 2.1-fold, respectively, without effect on lung RARs. Therefore, 13-cis-RA delivered to lung tissue of rats is a potent stimulant of lung but not liver RARs. Conversely, dietary RA stimulates liver but not lung RARs. These data support the concept that epithelial delivery of chemopreventive retinoids to lung tissue is a more efficacious way to attain up-regulation of TGase II and the retinoid receptors and possibly to achieve chemoprevention.




This article has been cited by other articles:


Home page
ChestHome page
M. D. Roth, J. E. Connett, J. M. D'Armiento, R. F. Foronjy, P. J. Friedman, J. G. Goldin, T. A. Louis, J. T. Mao, J. R. Muindi, G. T. O'Connor, et al.
Feasibility of retinoids for the treatment of emphysema study.
Chest, November 1, 2006; 130(5): 1334 - 1345.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H.-J. Lehmler, A. Fortis-Santiago, D. Nauduri, and P. M. Bummer
Interaction of long-chain nicotinates with dipalmitoylphosphatidylcholine
J. Lipid Res., March 1, 2005; 46(3): 535 - 546.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J L Mulshine and R A Smith
Lung cancer * 2: Screening and early diagnosis of lung cancer
Thorax, December 1, 2002; 57(12): 1071 - 1078.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. M. Lippman, J. J. Lee, D. D. Karp, E. E. Vokes, S. E. Benner, G. E. Goodman, F. R. Khuri, R. Marks, R. J. Winn, W. Fry, et al.
Randomized Phase III Intergroup Trial of Isotretinoin to Prevent Second Primary Tumors in Stage I Non-Small-Cell Lung Cancer
J Natl Cancer Inst, April 18, 2001; 93(8): 605 - 618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.